The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

4/BA.5 and original strains of SARS-CoV-2, compared to mRNA-1273.222, Moderna’s previously approved bivalent Omicron BA.4/BA.5-targeting COVID vaccine. Per management, the benefit was primarily ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...

and mRNA-1273 (Moderna) vaccine, respectively. This contrasts with 10 extra cases of myocarditis per 1 million positive SARS-CoV-2 tests (figure 1).1 However, no confirmed cases of athletes with ...

mRNA-1345 plus bivalent COVID-19 mRNA-1273.214, or mRNA-1273.214 plus placebo. In both parts, patients received vaccines and placebo via intramuscular injection into the deltoid muscle ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

They included participants who received mRNA vaccines (BNT162b2 or mRNA-1273) or adenoviral vector vaccines (Ad26.COV2.S) from January 2022 to December 2023. Those who hadn’t received ...